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Abstract
Background: The cannabinoid cannabinoid type 1 (CB1) neutral antagonist tetrahydrocannabivarin (THCv) has been suggested 
as a possible treatment for obesity, but without the depressogenic side-effects of inverse antagonists such as Rimonabant. 
However, how THCv might affect the resting state functional connectivity of the human brain is as yet unknown.
Method: We examined the effects of a single 10 mg oral dose of THCv and placebo in 20 healthy volunteers in a randomized, 
within-subject, double-blind design. Using resting state functional magnetic resonance imaging and seed-based connectivity 
analyses, we selected the amygdala, insula, orbitofrontal cortex, and dorsal medial prefrontal cortex (dmPFC) as regions of 
interest. Mood and subjective experience were also measured before and after drug administration using self-report scales.
Results: Our results revealed, as expected, no significant differences in the subjective experience with a single dose of THCv. 
However, we found reduced resting state functional connectivity between the amygdala seed region and the default mode 
network and increased resting state functional connectivity between the amygdala seed region and the dorsal anterior 
cingulate cortex and between the dmPFC seed region and the inferior frontal gyrus/medial frontal gyrus. We also found 
a positive correlation under placebo for the amygdala-precuneus connectivity with the body mass index, although this 
correlation was not apparent under THCv.
Conclusion: Our findings are the first to show that treatment with the CB1 neutral antagonist THCv decreases resting 
state functional connectivity in the default mode network and increases connectivity in the cognitive control network and 
dorsal visual stream network. This effect profile suggests possible therapeutic activity of THCv for obesity, where functional 
connectivity has been found to be altered in these regions.
Keywords:  Cannabinoids, default mode, fMRI, obesity, resting state, reward
Introduction
Despite severe health and economic consequences of excess 
body weight (Andreyeva et al., 2004), the neurobiological mech-
anism of disordered eating in humans remains unclear. The 
endocannabinnoid system in the human brain, which involves 
cannabinoid type 1 (CB1) receptors, has been implicated in 
reward processing in animals and humans (Solinas et al., 2007) 
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and in regulating feeding behavior by modulating brain reward 
signals related to appetite and the consumption of food (Solinas 
et  al., 2008). For example, when tetrahydrocannabinol (THC), 
which is a psychoactive constituent of the cannabis plant and 
a partial agonist at the CB1 receptor, was administered in rats 
it led to an increase in the hedonic response to sucrose and a 
decrease in aversive reactions to bitter solutions (Jarrett et al., 
2005). Moreover, Solinas and Goldberg reported that administra-
tion of THC, during food consumption, increased the motivation 
to respond for the food in rats (Solinas and Goldberg, 2005).
Rimonabant, an antagonist and possible inverse agonist 
(Pertwee, 2005) at the CB1 receptor, was licensed in Europe for 
the treatment of obesity in 2006 but was withdrawn from clini-
cal use in 2008 due to depression-like side effects. Rimonabant 
was found to promote weight loss by decreasing food intake 
(Scheen et al., 2006); however, it also presented with depression- 
and anxiety-related side effects. In an attempt to try and under-
stand how these treatments might be having their effects, we 
did a study in 2010 that examined the neural response to reward 
and aversion in humans after a 7-day treatment with rimona-
bant (Horder et  al., 2010). We found that rimonabant reduced 
neural responses to a pleasant chocolate taste in reward areas 
of the brain such as the ventral striatum and orbitofrontal cor-
tex (OFC), whilst increasing brain responses to aversive sights 
and tastes in regions such as the lateral OFC (Horder et al., 2010). 
We concluded that although reduced food intake might be due 
to a reduced neural response to reward, this may also have been 
a mechanism by which depression side-effects were induced, 
given that reduced neural responses to reward have been found 
in depressed patients (Keedwell et al., 2005; Wacker et al., 2009) 
and in those at risk of depression (McCabe et al., 2009, 2012) and 
are thought to be a possible biomarker for depression (Hasler 
and Northoff, 2011).
THCv, a neutral antagonist that acts on CB1 receptors, has 
been suggested as a potentially safer alternative with fewer 
side effects (Le Foll et al., 2009; Pacher and Kunos, 2013). Animal 
studies have shown that, like rimonabant, THCv reduces weight 
gain and food consumption but, unlike rimonabant, does not 
increase activity in the basolateral amygdala and ventral tag-
mental area: brain regions involved in emotion regulation (Meye 
et al., 2013). Moreover, our recent fMRI study, the first to investi-
gate THCv effects on reward and aversion in the healthy human 
brain, found that relative to placebo, THCv increased activation 
to pleasant chocolate stimuli in the anterior cingulate cortex, 
caudate, putamen, and midbrain (Tudge et  al., 2014), opposite 
to the profile of those at risk of depression (McCabe et al., 2009, 
2012). Thus, our results supported the idea that THCv does not 
impair reward function, and this may be related to a potentially 
safer side-effect profile.
We also found that THCv increased activation to the aversive 
stimulus in the amygdala, insula, and OFC (Tudge et al., 2014). 
We suggested this might be a mechanism to reduce food intake, 
by increasing the salience of food and perhaps then decreasing 
the time to satiety. This is plausible in light of a study by Tallett 
et al. (2008), which found that the behavioral satiety sequence 
(time to stop feeding) was accelerated under a rimonabant and 
naloxone combination in rats (Tallett et al., 2008). However, how 
THCv might affect activity in these regions at rest in healthy 
individuals is as yet unknown.
Therefore, in this study we aimed to investigate the effects 
of a single oral 10 mg dose of THCv on resting state functional 
connectivity between the regions of interest (ROI)—the amyg-
dala, insula, and the OFC—identified from our previous task find-
ings (Tudge et  al., 2014). Further, these regions have also been 
identified as altered in connectivity in studies of a resting state in 
obese individuals (Lips et al., 2014; Coveleskie et al., 2015; Zhang 
et al., 2015). We also selected the dorsal medial prefontal cortex 
(dmPFC) region, as we are interested in THCv’s effects on the pre-
frontal regions, especially those known to be involved in resting 
state functional connectivity in depression (Sheline et al., 2010). 
We hypothesized that, relative to placebo, THCv would increase 
the region of interest functional connectivity, in line with our 
effects found during a task (Tudge et al., 2014).
Methods
Participants
Nineteen participants (nine female), aged 20–36 were included 
in a within-subjects, double-blind, placebo-controlled, crossover 
design and received a single dose of oral treatment with THCv 
(10 mg/day) or placebo. Participants completed the resting state 
scan once with the drug (10 mg THCv approximately 1 hour before 
scan to allow for peak blood plasma levels to occur) and then 
again 1 week later with the placebo, or vice versa. Both participant 
and experimenter were blind to the treatment condition. Ethical 
approval was provided by the Oxford Research Ethics Committee 
and written informed consent was obtained from all participants 
before screening and after a complete description of the study 
was given. Participants were recruited from the university volun-
teer register and via internet adverts. Volunteers were assessed 
with the Structured Clinical Interview for DSM-IV Axis I Disorders 
Schedule (First et al., 1997) to exclude a current or previous his-
tory of major depression or any other Axis 1 disorder. Participants 
also had no history of drug or alcohol misuse and did not smoke 
more than five cigarettes a day. Participants were right handed, 
had normal or corrected-to-normal vision, and were not on med-
ications apart from the contraceptive pill. Participants had no 
neurological disorders or contraindications for MRI examination.
Baseline ratings of mood and anhedonia were collected using 
the Beck Depression Inventory (Beck et al., 1961), the Fawcett-
Clarke Pleasure Scale (Fawcett et al., 1983), the Snaith-Hamilton 
Pleasure Scale (Snaith et al., 1995), and the Temporal Experience 
of Pleasure Scale (Gard et al., 2007). Body mass index (BMI) and 
an Eating Attitudes questionnaire were used to rule out eating 
disorders (EAT; Garner et  al., 1982). Participants were scanned 
twice: once with THCv or placebo and then 1 week later with the 
other. To assess the effects of the treatment, the following ques-
tionnaires were taken before and after the treatment: Visual 
Analogue Scales (VAS) of happiness, sadness, anger, disgust, 
alertness, and anxiety; and the Befinldichkeit Scale of mood and 
energy (BFS; von Zerssen et al., 1974).
Experimental Design
MRI-derived measures of brain function, based on blood-oxygen-
ation-level-dependent (BOLD) contrast, were used to compare 
brain responses at rest across the THCv and the placebo groups 
at approximately 1 hour after treatment. The resting state data 
were acquired before any other scans, including the structural 
scan. Subjects were instructed to keep their eyes open while lying 
in the dimmed light of the scanner, looking at a black screen.
fMRI Data Acquisition
Images were acquired with a 3.0-T VARIAN/SIEMENS whole-
body scanner at the Oxford Centre for Functional Magnetic 
Resonance Imaging (FMRIB), where T2*-weighted echo planar 
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imaging (EPI) slices were acquired every 2.41 seconds (TR = 2.41). 
Imaging parameters were selected to minimize susceptibility 
and distortion artifacts in the OFC (Wilson et al., 2002). Coronal 
slices with in-plane resolutions of 3.0 x 3.0 mm and between-
plane spacings of 3 mm were obtained. The matrix size was 64 x 
64 and the field of view was 192 x 192 mm. Acquisition was car-
ried out during the resting scan, yielding 128 volumes in total. 
A  whole-brain T2*-weighted EPI volume of the above dimen-
sions, and an anatomical T1 volume with coronal plane slice 
thicknesses of 3 mm and in-plane resolutions of 1.0 x 1.0 mm 
were also acquired to improve the registration process.
Analysis Methods
Pre-Processing
Imaging data were pre-processed and analyzed using FSL tools 
(www.fmrib.ox.ac.uk/fsl; Smith et al., 2004). fMRI data pre-pro-
cessing was carried out using FEAT (FMRI Expert Analysis Tool, 
Version 6.0, a part of FSL software), and included the follow-
ing steps: non-brain removal (Smith, 2002); motion correction 
using MCFLIRT (Jenkinson and Smith, 2001); spatial smoothing 
using a Gaussian kernel of full-width at half maximum of 5 mm; 
grand mean intensity normalization of the entire 4D dataset 
by a single multiplicative factor; and high-pass temporal filter-
ing (Gaussian-weighted least-squares straight line fitting, with 
sigma = 64.0 s). fMRI volumes were registered to the individual’s 
structural scan and the MNI-152 standard space image (Montreal 
Neurological Institute) using FMRIB’s Linear Image Registration 
Tool (Jenkinson et al., 2001).
Time Series Extraction and Higher Level Analysis
To study resting state functional connectivity, a seed-based 
correlation approach was used with the amygdala, OFC, and 
insula as selected seeds using the Harvard-Oxford subcortical 
structural atlas (Kennedy et  al., 1998). To maximize the exact 
coverage, the masks of these seed regions were threshold by 
20% to include voxels having at least 20% in these particular 
regions. We also created seeds for the dmPFC (18 34 29; -24 35 
28; 8 mm radius) using coordinates from Sheline et al. (2010), as 
they showed this region to have increased connectivity within 
the default mode and affective network in depressed patients. 
The dmPFC seeds were created with the Wake Forest University 
Pickatlas tool in SPM8 (McCabe et al., 2010).
The mean time course within the left and right seeds of each 
ROI (except for the OFC, only comprising one medial seed) was 
calculated and used as a regressor in a general linear model 
for each of the networks. In addition, white matter and cere-
brospinal fluid were segmented using FSL’s FAST, and the six 
motion parameters (three translations and three rotations) and 
the global signal obtained from the pre-processing steps were 
all used as nuisance regressors. The resulting segmented white 
matter and cerebrospinal fluid images were then thresholded to 
ensure 80% tissue-type probability. For each individual, the gen-
eral linear model was analyzed using the FMRI Expert Analysis 
Tool (version 5.4, part of FMRIB’s Software Library; Smith et al., 
2004). The resulting parameter estimate maps were then ana-
lyzed using higher level one-sample t-tests for group averages 
and paired-samples t-tests for treatment effects. Whole-brain 
z-statistical images were thresholded with an initial cluster-
forming threshold of z > 2.3 and a corrected cluster significance 
threshold of p < 0.008 (i.e. p < 0.05 Bonferroni corrected for the 
six regions of interest: the right and left amygdala, right and 
left insula, OFC, and dmPFC (Worsley, 2001). The % BOLD signal 
change in the graphs is the PE/COPE values converted to mean 
% BOLD signal change via Featquery (FSL; www.fmrib.ox.ac.uk/
fsl; Smith et al., 2004) for the regions that had significant correla-
tions with the seeds (Table 2).
BMI Correlations
To examine the relationship with BMI, we took the % BOLD 
signal change from voxels identified as significantly different 
between the drug and placebo (Table 2) using Featquery in each 
individual subject and then correlated this with the BMI scores 
for each individual.
Results
Demographic Details and Mood Ratings
Demographic data analysis (Supplementary Table S1) revealed 
participants had low depression scores, as well as normal EAT 
scores. One-way ANOVAs revealed no significant effects of gen-
der on any of the demographic measures (p > 0.05). Repeated-
measures ANOVAs were employed to examine the effect of drug 
(placebo/THCv) and time (pre-scan/post-scan) on scores of mood, 
energy, and affect, as measured by the BFS and VAS. Results 
revealed there was no main effect of drug on mood, energy, or 
affect (p > 0.05; Supplementary Table S2). In order to assess any 
potential confounding effects of gender or order on mood, energy, 
and affect scores, gender and order were included in the analyses 
as independent variables. No main effects of gender or order and 
no gender x drug or order x drug interactions were revealed, sug-
gesting that the order of drug condition and the gender of the par-
ticipant did not have an effect on mood, energy, and affect ratings.
Functional Connectivity: Placebo
The functional connectivity for the seed regions is described in 
Supplementary Table S3 for the placebo group alone (baseline). 
Overall, the patterns of connectivity associated with each of the 
seed regions are consistent with resting state and functional 
connectivity experiments in healthy controls and obese patients 
or depressed patients (Anand et al., 2005; Greicius et al., 2007; 
Leh et al., 2007; Robinson et al., 2009; Sheline et al., 2010; Cauda 
et al., 2011; Kullmann et al., 2012).
Functional Connectivity of the A-priori Seeds
Left Amygdala Seed 
Compared to the placebo group, there was reduced functional 
connectivity between the left amygdala seed and the left pre-
cuneus and the left posterior cingulate cortex (PCC), key areas 
constituting the default mode network (DMN) in the THCv group 
(Figure 1). There was also decreased connectivity with the lateral 
occipital cortex, but this did not meet the Bonferroni correction.
There was also increased functional connectivity between 
the left amygdala seed and the dorsal anterior cingulate gyrus/
premotor area, which overlaps with the executive control net-
work, in the THCv group (Table 1; Figure 2).
Functional Connectivity for the Exploratory Seeds
Right dmPFC Seed 
Compared to the placebo group, there was an increased func-
tional connectivity between the right dmPFC seed and the right 
inferior frontal gyrus/medial frontal gyrus (IFG/MFG), which 
overlaps with the right dorsal visual stream network in the 
THCv group (Table 1; Figure 3).
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Correlation with BMI
We found a positive correlation between the % BOLD signal 
change extracted from the precuneus (the area that correlated 
with the amygdala seed region) and BMI (r = 0.649; p = 0.003) in 
the placebo group that was not present under THCv (r = 0.38; 
p = 0.1; Figure 4), with the difference scores between placebo and 
THCv plotted in Figure 4B. Further, when the outlier that was 
higher than two standard deviations from the mean (%  BOLD 
change 1.5) was removed from the placebo group, the correla-
tion with the BMI was still significant, at r = 0.591 and p = 0.01. 
We did not find a significant correlation between the BMI and 
brain connectivity for any of the other seed ROIs.
Discussion
Our study reveals that administration of a single THCv oral dose 
modulates resting state functional connectivity in a double-blind 
Figure 2. Coronal, sagittal, and axial slices showing the amygdala seed region and functional connectivity maps for the difference between placebo and tetrahydrocan-
nabinol (THCv) groups, overlaid on the executive control network. The right graph displays the % blood-oxygenation-level-dependent signal change extracted from the 
region of significant treatment effect. Dorsal anterior cingulate cortex: 6 4 52 and p = 0.00001 for the placebo group and THCv group.
Figure 1. Coronal, sagittal, and axial slices showing the amygdala seed region and functional connectivity maps for the difference between placebo and tetrahydrocan-
nabinol (THCv) groups, overlaid on the default mode network. The right graph displays the % blood-oxygenation-level-dependent signal change extracted from the 
region of significant treatment effect. Precuneus: − 8 -72 24 and p = 0.0009 for the placebo group and THCv group.
Table 1. Resting state functional connectivity for brain seed regions and the effects of THCv.
Brain region
MNI coordinates
z-score Number of voxels
Significance
(p-value)X Y Z
Placebo > THCv
L Amygdala seed
Precuneus -8 -72 24 3.41 333 0.0009
PCC -2 -58 30 2.74 333 0.003
Lateral Occipital Cortex -44 -70 30 4 283 0.034*
THCv > Placebo   
L Amygdala seed
dACC/Supplementary motor cortex 6 4  52  3.89 501  0.00001
R dmPFC seed
IFG/MFG 52 28 22 3.47 224 0.003
Gender was added as a covariate of no interest. All z values were cluster corrected for multiple comparisons (z > 2.3, p < 0.008) except *. dACC, dorsal anterior cingu-
late cortex; IFG/MFG, inferior frontal gyrus/medial frontal gyrus; MNI, Montreal Neurological Institute; PCC, posterior cingulate cortex; THCv, tetrahydrocannabinol.
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placebo-controlled design in healthy volunteers, despite no sig-
nificant effects on mood. Specifically, we found that resting state 
functional connectivity was reduced between the left amygdala 
and parts of the DMN (left precuneus and the PCC) for the THCv 
group when compared with the placebo group.
Previous studies in obese individuals have revealed increased 
activity in DMN regions, specifically in the precuneus and PCC, 
when compared with healthy subjects (Tregellas et  al., 2011). 
Further, these brain areas have been highlighted in studies 
investigating obese versus lean individuals’ visual responses 
to food cues and tastes (DelParigi et  al., 2005; Cornier, 2009), 
suggesting an involvement in feeding behavior. Moreover, the 
posterior cingulate cortex has been found to play a crucial role 
in switching spatial attention to targets of salient and motiva-
tional value: i.e. directing attention to food stimuli in subjects 
experiencing hunger (Mohanty et al., 2008). Additionally, corre-
lational analysis of the key nodes within the DMN revealed that 
the posterior cingulate cortex is involved in retrieving and inte-
grating information from other subsystems implicated in self-
referential thoughts and episodic memory (Hassabis et al., 2007; 
Buckner et al., 2008). Thus, increased activation of DMN in obese 
individuals has been suggested as a reflection of greater atten-
tion to internal states and memories influenced by past experi-
ence with food (Tregellas et al., 2011). Further, our reduced DMN 
connectivity under THCv might also be related to the reported 
safer side effect profile of THCv (less depression), as depressed 
patients have been found to have greater DMN connectivity 
(Sheline et al., 2010). Therefore it would be interesting to see if 
our result of decreased connectivity with the DMN under THCv 
could be replicated in obese patients and how this might relate 
to food intake and depression symptoms.
We also found increased connectivity between the left 
amygdala and the dorsal anterior cingulate cortex extend-
ing into the supplementary motor cortex, part of the execu-
tive control network, as well as an increased connectivity 
between the dmPFC and the IFG/MFG, part of the dorsal visual 
stream network. The executive control network is consist-
ently recruited by cognitively demanding tasks of attention, 
working memory, and response selection (Seeley et al., 2007). 
Specifically, the dorsal regions of the PFC have been implicated 
in response activation and inhibition as investigated by GO/
NOGO tasks (Garavan et al., 2002). Additionally, a study investi-
gating neural activations during a food-specific GO/NOGO task 
in obese adolescents found reduced activation in the medial 
PFC when the participants were required to inhibit proponent 
responses to food, suggesting hypofunctioning of inhibitory 
control in obese individuals (Batterink et  al., 2010). Thus our 
results of increased connectivity between the amygdala seed 
region and regions such as the anterior cingulate in the execu-
tive control network under THCv might help us understand 
Figure 3. Coronal, sagittal, and axial slices showing the right dorsal medial prefrontal cortex seed region and functional connectivity maps for the difference between pla-
cebo and tetrahydrocannabinol (THCv) groups, overlaid on the right dorsal visual stream network. The right graph displays the % blood-oxygenation-level-dependent signal 
change extracted from the region of significant treatment effect. inferior frontal gyrus/medial frontal gyrus: 52 28 22 and p = 0.003 for the placebo group and THCv group.
Figure 4. Graph of the % blood-oxygenation-level-dependent signal change extracted from the region of significant treatment effect: precuneus [− 8 -72 24 p = 0.0009] 
and correlated with body mass index (BMI) score for placebo and tetrahydrocannabinol (THCv).
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how, at a mechanistic level, THCv could allow greater control 
over food intake.
Finding increased dmPFC connectivity with the IFG/MFG part 
of the dorsal visual stream resting state network under THCv is 
interesting, given that a recent study suggests that just thinking 
about eating food shown in images increases activation in the 
visual and prefrontal cortical regions in females with anorexia 
nervosa (Brooks et al., 2012). The authors concluded that such 
activations might underlie the biases toward controlling food 
intake commonly observed in individuals with anorexia ner-
vosa (Brooks et al., 2012). Thus it is possible that increased con-
nectivity between the dmPFC and visual networks under THCv 
might further enable THCv as a treatment to control food intake. 
Although there are as yet no other resting state studies on THCv 
in humans, there has been a study showing that the CB1 recep-
tor agonist δ9-tetrahydrocannabinol, THC, increases functional 
connectivity between the dmPFC and the right dorsal visual 
stream network (Klumpers et al., 2012): this is directly opposite 
to our findings but consistent, as THCv is a neutral antagonist. 
Klumpers et al. discussed their findings with THC in relation to 
the known involvement of the dmPFC in decision making and 
cognitive control from previous behavioral studies also showing 
how THC can interfere with these processes.
Examining the relationship between BMI and brain results, we 
found a significant positive correlation between amygdala-precu-
neus connectivity under placebo but not under THCv. This seems 
to indicate that as BMI increases, functional connectivity between 
these regions increases, and that THCv removes this effect, espe-
cially at the top end of the BMI (see Figure  4). However, as our 
group did not contain obese individuals, a future study relating 
a greater range in BMI and resting state functional connectivity 
with pharmacological treatment effects would be very interesting.
Thus, in conclusion, our results show that THCv can modu-
late resting state functional connectivity in key networks such 
as the default mode network and the cognitive control network, 
and this might be relevant to the development of THCv as an 
anti-obesity medication. Future studies are needed to examine 
the relationship between resting state functional connectivity 
after repeated treatment with THCv in overweight individuals 
and how this relates to control over food intake.
Supplementary Material
For supplementary material accompanying this paper, visit 
http://www.ijnp.oxfordjournals.org/
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